All News
Filter News
Found 6,659 articles
-
BioRestorative Therapies, Inc. Announces Next Generation of Stem Cell Disc Delivery Device
5/3/2012
-
UCB, Inc. Release: First Assessment of Individual RLS Domains In New Post-Hoc Analyses of Neupro(R) Studies
4/26/2012
-
Pharming Group Reports Financial Results First Quarter 2012
4/26/2012
-
BioElectronics Corporation' Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
4/25/2012
-
AcelRx Pharmaceuticals Announces Hiring of Kim Gaumer as Vice President, Regulatory Affairs and Quality Assurance
4/17/2012
-
MAP Pharmaceuticals, Inc. to Meet FDA to Discuss Manufacturing Issues; Provides Update on LEVADEX
4/16/2012
-
AcelRx Pharmaceuticals Announces Initiation of Second Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Acute Post-Operative Pain
4/12/2012
-
BioRestorative Therapies, Inc. Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
4/11/2012
-
AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal Dosage Forms
4/11/2012
-
EpiCept Corporation's AmiKet™ Receives Fast Track Designation from FDA
4/10/2012
-
UCB, Inc.'s Neupro® Approved by FDA for Parkinson's Disease and Restless Legs Syndrome
4/4/2012
-
Unigene Laboratories, Inc.'s Proprietary Oral Peptide Delivery Platform is Further Validated with Cara Therapeutics' Successful Completion of its Phase 1 Study Using Unigene's Oral Formulation of Novel Kappa Opioid Receptor Agonist, CR845
4/3/2012
-
Cara Therapeutics, Inc. Successfully Completes Phase I Study With Oral Formulation of its Novel Kappa Opioid Receptor Agonist, CR845
4/3/2012
-
Abcam plc Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute
4/3/2012
-
Nektar Therapeutics (CA) Doses First Subjects in Phase 1 Clinical Study Evaluating NKTR-192, a New Short-Acting Opioid Molecule for the Treatment of Acute Pain
4/2/2012
-
MAP Pharmaceuticals, Inc. Reports 2011 Fourth Quarter and Year End Financial Results
3/29/2012
-
First Patient Treated in Trillium Therapeutics Inc.'s Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial
3/28/2012
-
SoundCure, Inc. Launches the Serenade(R) Tinnitus Treatment System With FDA Clearance and CE Mark
3/27/2012
-
Teva Pharmaceutical Industries Limited Gets FDA Approval for "Dry" Allergy Aerosol QNASL
3/27/2012
-
INSYS Therapeutics Announces the Availability of SUBSYS(TM) (Fentanyl Sublingual Spray) for Breakthrough Cancer Pain
3/26/2012